Tms denied as non-formulary by UnitedHealthcare?
Non-formulary doesn't mean uncoverable. Most plans have a formulary-exception process: the appeal needs to show the formulary alternatives are inappropriate for your specific clinical situation.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What UnitedHealthcare typically requires
Adult MDD with TRD: documented failure of >=4 antidepressants from >=2 classes at adequate dose/duration, plus psychotherapy. Standard course up to 36 sessions.
What works in the appeal
Cite THREE-D (Blumberger 2018, Lancet) — iTBS noninferior to standard rTMS. Carpenter 2012 multisite study — response often emerges sessions 20-30, full benefit at 36. FDA clearance for NeuroStar/BrainsWay. Premature termination violates standard of care. For UBH-administered plans, invoke Wit findings re: standards of care.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →